Cocrystal Pharma, Inc. (NASDAQ:COCP – Get Free Report) was the recipient of a significant decline in short interest in February.As of February 15th, there was short interest totalling 14,400 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback